Last C$0.12 CAD
Change Today -0.005 / -4.17%
Volume 140.0K
SBM On Other Exchanges
Symbol
Exchange
Venture
OTC US
Frankfurt
As of 2:01 PM 10/30/14 All times are local (Market data is delayed by at least 15 minutes).

sirona biochem corp (SBM) Snapshot

Open
C$0.12
Previous Close
C$0.12
Day High
C$0.12
Day Low
C$0.11
52 Week High
08/6/14 - C$0.20
52 Week Low
07/18/14 - C$0.09
Market Cap
14.4M
Average Volume 10 Days
140.1K
EPS TTM
C$-0.03
Shares Outstanding
125.0M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for SIRONA BIOCHEM CORP (SBM)

Related News

No related news articles were found.

sirona biochem corp (SBM) Related Businessweek News

No Related Businessweek News Found

sirona biochem corp (SBM) Details

Sirona Biochem Corp. operates as a cosmetic ingredient and drug discovery company in Canada. The company develops programs in three areas, including diabetes and cancer therapeutics; anti-aging and depigmenting agent in cosmeceuticals; biological ingredients, such as inducers and adjuvants for biological development. It develops a sodium glucose co-transporter inhibitor for the treatment of Type 2 diabetes; and a cancer vaccine antigen. The company was formerly known as High Rider Capital Inc. and changed its name to Sirona Biochem Corp. in May 2009. Sirona Biochem Corp. was incorporated in 2006 and is headquartered in Vancouver, Canada.

Founded in 2006

sirona biochem corp (SBM) Top Compensated Officers

Founder, Chairman of the Board, Interim Chief...
Total Annual Compensation: C$95.0K
Chief Financial Officer and Director
Total Annual Compensation: C$102.0K
Compensation as of Fiscal Year 2013.

sirona biochem corp (SBM) Key Developments

Sirona Biochem Names Attila Hajdu as Chief Business Development Officer

Sirona Biochem Corp. announced that it has named Mr. Attila Hajdu as Chief Business Development Officer. Prior to joining Sirona Biochem, Attila held various senior leadership positions within GlaxoSmithKline and Astellas Pharma, accumulating 17 years of experience in Sales, Marketing, R&D Finance, Medical Affairs and Business Development.

Sirona Biochem Corp. Announces Research Collaboration with Aegilops Applications

Sirona Biochem Corp. announced a collaboration with Aegilops Applications. Aegilops specializes in the protection of plant seeds. The objective of the research collaboration is to develop a novel compound to improve germination and growth in plants, thereby enhancing crop production. Sirona Biochem's TFChem has, in its portfolio, a compound that Aegilops will evaluate on different crops in seed treatment for potent agrochemical applications. According to the International Seed Federation (ISF), the global seed market was worth approximately $47 billion in 2012 and estimates it to be as high as $50 billion. Seeds are living things and improving seed vitality is of enormous commercial value to the agriculture industry.

Sirona Biochem Corp. Launches Anti-Aging Preclinical Studies

Sirona Biochem Corp. announced that it has launched the next stage of development for its anti-aging compound library. With recent funding from Bpifrance (the French Public Investment Bank) and the district of Haute Normandie, Sirona Biochem's subsidiary TFChem (France) moves into the next phase of the agreement with the French laboratory Biogalenys. Biogalenys has been chosen to work with the team of scientists at TFChem to develop the studies on the anti-aging technology. The research will provide preclinical data supporting multiple targeted applications using novel in vitro tests with varying stress conditions and cell types. The purpose is to both validate the compounds, and to satisfy the standard cohort of cosmetic safety studies. The data will then be used to determine the optimal commercial applications and joint venture partners.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SBM:CN C$0.12 CAD -0.005

SBM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for SBM.
View Industry Companies
 

Industry Analysis

SBM

Industry Average

Valuation SBM Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 52.3x
Price/Book 8.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales 51.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SIRONA BIOCHEM CORP, please visit www.sironabiochem.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.